Cannapharm Technologies Malta Competitors and Similar CompaniesClear all
Avicanna's competitors and similar companies include AXIM Biotechnologies and BOL Pharma.
 Avicanna Avicanna is a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products. |  AXIM Biotechnologies AXIM Biotechnologies is a company focused on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products. |  BOL Pharma BOL Pharma is a company that offers cannabinoid related products and active pharmaceutical ingredients (APIs) to the pharmaceutical industry. | |
Founding Date | Founding Date 2016 | Founding Date 2010 | Founding Date 2007 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Toronto, CA HQ | Locations New York, US HQ San Diego, US | Locations Revadim, IL HQ |
Employees | Employees 87 | Employees 6 | Employees 343% decrease |
Valuation ($) | Valuation ($) 23.9 m | Valuation ($) 1.5 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $25.5m (FY, 2025) | Revenue (est.) $39.5k (FY, 2023) | Revenue (est.) $3.5m (FY, 2018) |
Cost of goods | Cost of goods $11.7m (FY, 2025) | Cost of goods N/A | Cost of goods $5.8m (FY, 2018) |
Gross profit | Gross profit $13.7m (FY, 2025) | Gross profit N/A | Gross profit ($2.3m) (FY, 2018) |
Net income | Net income ($2.8m) (FY, 2025) | Net income ($8.1m) (FY, 2023) | Net income ($29.4m) (FY, 2018) |
Funding | |||
Total funding raised | Total funding raised $ 1.2m | Total funding raised $ 115k | Total funding raised $ 2.9m |
For sources of this data, please see the company profile
View Company Profiles
AXIM Biotechnologies
HQ
New York, US
Employees
6
AXIM Biotechnologies is a company focused on the research, development, and production of cannabis-based pharmaceutical, nutraceutical, and cosmetic products.
View companyBOL Pharma
HQ
Revadim, IL
Employees
34↓ 3% decrease
BOL Pharma is a company that offers cannabinoid related products and active pharmaceutical ingredients (APIs) to the pharmaceutical industry.
View company